Literature DB >> 10658239

Economic evaluation of Viaflex with vial adapter in a unit-dose drug distribution system.

A Ortega1, A Robles, C Lacasa, B Elcarte, J Giráldez.   

Abstract

The cost of parenteral admixtures has an important impact on the hospital budget. Recently, a Viaflex with vial adapter (named 'minibag plus' in some countries) has been commercialized in order to facilitate parenteral admixture preparation. In the present study a preparation using Viaflex with a vial adapter has been economically compared with a preparation with a traditional Viaflex (without adapter) in a centralized unit or in nursing wards in a unit-dose drug distribution system. A cost-analysis was conducted from the hospital point of view. Direct costs were considered: these included supplies and human resources. Differences in the whole process between the two types of Viaflex were analysed. The process included: purchasing, reception, storage, medical order record, preparation in the Pharmacy Service (PS), delivery from the PS to the nursing unit, preparation by the nurse, return of unused material to the PS. Human resource costs were estimated by time counting and multiplying by the average salary. To estimate wasted material, drug and supplies delivered from the PS and returned to the PS were counted during 26 days. With the new Viaflex costs are reduced by 30% in comparison with drug dilution using the traditional Viaflex in a centralized unit of the PS, and by 13.4% in comparison with preparation with the traditional Viaflex in the nursing ward. In addition it can be estimated that contamination risk with the new Viaflex is lower than preparation in the nursing ward with the traditional Viaflex. Therefore, owing to its lower cost we recommend the use of Viaflex with vial adapter for drug dilution for those vials that are compatible with the system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10658239     DOI: 10.1023/a:1008738924846

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  5 in total

1.  Monitoring system to verify activation of ADD-Vantage system doses.

Authors:  M S DeRon; S A Craig; N P Parks
Journal:  Am J Hosp Pharm       Date:  1989-04

2.  Considerations in using the i.v. route for drug delivery.

Authors:  M J Akers
Journal:  Am J Hosp Pharm       Date:  1987-11

3.  Evaluation of laminar air flow and nursing station environments for the preparation of intravenous admixtures.

Authors:  E Morgan; J H Fincher; F Sadik; R L Mikeal
Journal:  Am J Hosp Pharm       Date:  1972-12

4.  Potential for microbial contamination of ADD-Vantage admixtures.

Authors:  T J Hudson; E M Ambroziak; R M Coley
Journal:  J Pharm Technol       Date:  1992 Sep-Oct

5.  Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.

Authors:  K L Brier; C J Latiolais; P J Schneider; T D Moore; W J Buesching; B C Wentworth
Journal:  Am J Hosp Pharm       Date:  1981-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.